Treatment of hypertriglyceridemia with fenofibrate, fatty acid composition of plasma and LDL, and their relations to parameters of lipoperoxidation of LDL.
The purpose of this study was to determine oxidation and oxidability of VLDL and LDL in connection with changes in their composition and content of FA in LDL after treatment with fenofibrate in patients with HTG.
Zeman
M
M
Fourth Department of Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic. zemanm@vfn.cz
Zák
A
A
Vecka
M
M
Tvrzická
E
E
Romaniv
S
S
Konárková
M
M
D000328:Adult; D000368:Aged; D005227:Fatty Acids / Q000097:blood / Q000378:metabolism*; D005260:Female; D011345:Fenofibrate / Q000627:therapeutic use*; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D015227:Lipid Peroxidation; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008297:Male; D008875:Middle Aged
D005227:Fatty Acids; D000960:Hypolipidemic Agents; D008077:Lipoproteins, LDL; D011345:Fenofibrate